Improving predictability and transparency in DEA and FDA regulation

An edition of Improving predictability and transparency in DEA and FDA regulation (2015)

Improving predictability and transparency in DEA and FDA regulation

hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

Publish Date

2015

Publisher

U.S. Government Publishing Office

Language

eng

Pages

217

1-1 of 1 Editions

Improving predictability and transparency in DEA and FDA regulation

Improving predictability and transparency in DEA and FDA regulationhearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

Language: eng

Pages: 217

Published In: 2015

Publisher: U.S. Government Publishing Office